3Montalban J,Rio J,Khamashta M,et al. Value of immunologic testing in stroke patients. A prospective multicentre study.Stroke 1994.25:2412 被引量：1
4Brey RL,Coull BM. Antiphospholipid antibodies: origin. Specificity and mechanism of action. Stroke, 1992,23 (suppl 1 ):15 被引量：1
5Levine SR,Brey RL,Sawaya KL.et al. Recurrent stroke and thrombo-occlusive event in the antiphospholipid syndrome. Ann Neurol, 1995,38:119 被引量：1
6Provenzale JM, Barboriak DP, Allen NB, et al. Patients with antiphospholipid antibodies :CT and MR findings of the brain,AJR-Am-J-Roentgenol, 1996,167:1573 被引量：1
7Muir KW. Squire IB, Alwan W,et al. ACA in an unselected stroke population. Lancet, 1994,344: 452 被引量：1
8Kushner MJ. Prospective study of anticardiolipin antibodies in stroke. Stroke,1990.21:295 被引量：1
9APASS Group. Anticardiolipin antibodies are independent risk factor for first ischemic stroke. Neurology l993,43:2069 被引量：1
10Camerlingo M, Casto L, Censori B. et al. Anticardiolipin antibodies in acute nonhemorrhagic stroke seen within six hours after stroke onset. Acta Neurol Scand,1995,92:69 被引量：1
